XML 88 R78.htm IDEA: XBRL DOCUMENT v3.6.0.2
Fair Value Measurements - Narrative (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Nov. 28, 2016
Dec. 31, 2016
Sep. 30, 2016
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Loss on settlement of financial instruments   $ 231  
Available-for-sale securities   6,083 $ 6,135
Note receivable, face value   200 200
Equity method investments   25,295 27,273
Fair Value, Measurements, Recurring      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Cash equivalents   185 143
Available-for-sale securities   6,083 6,135
Foreign exchange contracts   34 5
Foreign exchange contracts   86 97
Stock warrant, fair value (less than $0.1 million)     45
Contingent consideration     500
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Cash equivalents   140 98
Available-for-sale securities   0 0
Foreign exchange contracts   0 0
Foreign exchange contracts   0 0
Stock warrant, fair value (less than $0.1 million)     0
Contingent consideration     0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Cash equivalents   45 45
Available-for-sale securities   6,083 6,135
Foreign exchange contracts   34 5
Foreign exchange contracts   86 97
Stock warrant, fair value (less than $0.1 million)     0
Contingent consideration     0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3)      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Cash equivalents   0 0
Available-for-sale securities   0 0
Foreign exchange contracts   0 0
Foreign exchange contracts   0 0
Stock warrant, fair value (less than $0.1 million)   0 45
Contingent consideration     500
BioCision, LLC      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Equity method investments $ 1,200   1,700
Equity method investments, fair value disclosure   $ 3,100  
BioCision, LLC | Significant Unobservable Inputs (Level 3)      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Risk free interest rate (as a percent)   0.96%  
Expected payoff period (in years)   1 year 6 months  
Expected volatility rate (as a percent)   80.00%  
Equity value   $ 6,500  
Other Assets | Permanent Term Loan, Tranche One | BioCision, LLC      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Carrying value of loan receivable     1,500
Carrying value of bridge loans plus principal and accrued interest     1,500
Convertible Debt Securities      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Fair value of convertible debt securities   0 5,774
Settlements 5,580 $ 5,580  
Share price (in dollars per share)   $ 1.76  
Change in fair value (194) $ (194)  
Convertible Debt Securities | Significant Unobservable Inputs (Level 3)      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Fair value of convertible debt securities     5,800
Discount rate (as a percent)   23.00%  
Risk-adjusted discount rate (as a percent)   23.00%  
Expected volatility rate (as a percent)   55.00%  
Stock Warrants      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Fair value of convertible debt securities   $ 0 45
Settlements   8  
Change in fair value   (37)  
Money Market Funds | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Cash equivalents   100  
Certificates of Deposit | Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Cash equivalents   $ 100 $ 100
Minimum | Convertible Debt Securities | Significant Unobservable Inputs (Level 3)      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Payout period (in years)   1 year 6 months  
Risk free interest rate (as a percent)   0.96%  
Expected payoff period (in years)   1 year 6 months  
Maximum | Convertible Debt Securities | Significant Unobservable Inputs (Level 3)      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Payout period (in years)   3 years 2 months 12 days  
Risk free interest rate (as a percent)   1.39%  
Expected payoff period (in years)   3 years 22 days  
Contact Co., Ltd      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Payment of contingent consideration   $ 500  
Cool Lab, LLC      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Carrying value of loan receivable 1,600    
Carrying value of bridge loans plus principal and accrued interest 1,600    
Cool Lab, LLC | Significant Unobservable Inputs (Level 3)      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Stock warrant, fair value (less than $0.1 million) 100    
Loans receivable, fair value disclosure 1,600    
Cool Lab, LLC | Convertible Debt Securities      
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]      
Carrying value of convertible debt securities $ 5,800